AGENT FOR TREATING ACUTE AND CHRONIC cerebral circulatory disorders, including stroke, BASED hydrogenated pyrido (4,3-b) Indoles (variants), Pharmacological BEING BASED THEREON AND METHOD FOR ITS USE

1. The use of hydrogenated pyrido (4,3-b) indoles of formula (1) as a means for the treatment of acute and chronic disorders of cerebral circulation, including insulta.v wherein R c is selected from the group consisting of CH, SNSN- or PhCH; R c is selected from the group consisting of H, PhCH- CH-or 6-3-Py- (CH) -; R c is selected from the group consisting of H, Br or CH-.2. Use according to claim 1, wherein Rsootvetstvuet CH-, R-H and R-CH-.3. Use according to claim 2, wherein the compound is in the form of (±) cis-izomera.4. Use according to claim 1, wherein said compounds are salts with pharmaceutically acceptable kislotami.5. The use of hydrogenated pyrido (4,3-b) indoles of Formula (2) as a means for the treatment of acute and chronic disorders of cerebral circulation, including insultav wherein R c is selected from the group consisting CH-, or SNSN- PhCH-; R c is selected from the group containing H-, PhCH- CH-or 6-W-Py- (CH) -, aRvybran from the group consisting of H, Br or CH-.6. Use according to claim 5, wherein Rsootvetstvuet SNSN- or PhCH-, Rsootvetstvuet H-, R- and N-.7. Use according to claim 5, wherein Rsootvetstvuet CH-, Rsootvetstvuet PhCH-, a R- CH-.8. Use according to claim 5, wherein Rsootvetstvuet CH-, -CH Rsootvetstvuet 6-3-Py- (CH) -, R- H-.9. Use according to claim 5, wherein Rsootvetstvuet CH-, -CH Rsootvetstvuet 6-3-Py- (CH) -, a R- CH-10. Use according to claim 5, wherein Rsootvetstvuet CH-, Rsootvetstvuet H-, R- and H- or CH-.11. Use according to claim 5, wherein Rsootvetstvuet CH-, Rsootvetstvuet H-, R- and Br-.12. Use according to claim 5, wherein said compounds are salts with pharmaceutically acceptable kislotami.13. Use according to claim 5, wherein the compound is dihydrochloride of 2,8-dimethyl-5- [2- (6-methyl-3-pyridyl) ethyl] -2,3,4,5-tetrahydro-1H-pyrido [4 , 3-b] indole (Dimebon) 14. Pharmacological agent for the treatment of acute and chronic impaired